期刊
PURINERGIC SIGNALLING
卷 9, 期 2, 页码 135-143出版社
SPRINGER
DOI: 10.1007/s11302-012-9342-3
关键词
Ischemia-reperfusion injury; Renal transplant; Purinergic signalling; Adenosine receptor; Ectonucleotidase
资金
- Perpetual Philanthropic Services
- Kidney Health Australia
Hypoxic injury occurs when the blood supply to an organ is interrupted; subsequent reperfusion halts ongoing ischemic damage but paradoxically leads to further inflammation. Together this is termed ischemia-reperfusion injury (IRI). IRI is inherent to organ transplantation and impacts both the short- and long-term outcomes of the transplanted organ. Activation of the purinergic signalling pathway is intrinsic to the pathogenesis of, and endogenous response to IRI. Therapies targeting the purinergic pathway in IRI are an attractive avenue for the improvement of transplant outcomes and the basis of ongoing research. This review aims to examine the role of adenosine receptor signalling and the ecto-nucleotidases, CD39 and CD73, in IRI, with a particular focus on renal IRI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据